JP2021095380A - Dentifrice composition - Google Patents
Dentifrice composition Download PDFInfo
- Publication number
- JP2021095380A JP2021095380A JP2019229443A JP2019229443A JP2021095380A JP 2021095380 A JP2021095380 A JP 2021095380A JP 2019229443 A JP2019229443 A JP 2019229443A JP 2019229443 A JP2019229443 A JP 2019229443A JP 2021095380 A JP2021095380 A JP 2021095380A
- Authority
- JP
- Japan
- Prior art keywords
- dentifrice composition
- fluoride
- retention
- component
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- 239000000551 dentifrice Substances 0.000 title claims abstract description 47
- 229920002678 cellulose Polymers 0.000 claims abstract description 18
- 239000001913 cellulose Substances 0.000 claims abstract description 18
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims abstract description 18
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 12
- 239000011775 sodium fluoride Substances 0.000 claims abstract description 9
- 235000013024 sodium fluoride Nutrition 0.000 claims abstract description 9
- 235000019832 sodium triphosphate Nutrition 0.000 claims abstract description 7
- 235000011180 diphosphates Nutrition 0.000 claims abstract description 6
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 claims abstract description 6
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims abstract 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical group [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 5
- 239000001110 calcium chloride Substances 0.000 claims description 5
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 5
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 claims description 4
- -1 fluorine ions Chemical class 0.000 abstract description 64
- 229910052731 fluorine Inorganic materials 0.000 abstract description 34
- 239000011737 fluorine Substances 0.000 abstract description 34
- 239000007788 liquid Substances 0.000 abstract description 27
- 238000000926 separation method Methods 0.000 abstract description 26
- 238000007711 solidification Methods 0.000 abstract description 20
- 230000008023 solidification Effects 0.000 abstract description 20
- 230000014759 maintenance of location Effects 0.000 description 39
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 37
- 210000000214 mouth Anatomy 0.000 description 24
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 17
- 238000002156 mixing Methods 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 13
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 210000002200 mouth mucosa Anatomy 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000011230 binding agent Substances 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 8
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 7
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 229910001634 calcium fluoride Inorganic materials 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 238000005227 gel permeation chromatography Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000000717 retained effect Effects 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 210000003296 saliva Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 229940127557 pharmaceutical product Drugs 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229940048084 pyrophosphate Drugs 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920000388 Polyphosphate Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical class C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 238000005498 polishing Methods 0.000 description 3
- 239000001205 polyphosphate Substances 0.000 description 3
- 235000011176 polyphosphates Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102100037644 Kelch-like protein 41 Human genes 0.000 description 2
- 108050003242 Kelch-like protein 41 Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- NPKKRSHVJIQBKU-UHFFFAOYSA-N ornogenin Natural products CC(OC(=O)C=Cc1ccccc1)C2(O)CCC3(O)C4(O)CC=C5CC(O)CCC5(C)C4CC(OC(=O)C=Cc6ccccc6)C23C NPKKRSHVJIQBKU-UHFFFAOYSA-N 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- IAEGWXHKWJGQAZ-UHFFFAOYSA-N trimethylpyrazine Chemical compound CC1=CN=C(C)C(C)=N1 IAEGWXHKWJGQAZ-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- VOYUSQRHBBSWFY-UHFFFAOYSA-N (2-amino-2-oxoethyl)-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC(N)=O VOYUSQRHBBSWFY-UHFFFAOYSA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- GRWFGVWFFZKLTI-YGPZHTELSA-N (5r)-4,6,6-trimethylbicyclo[3.1.1]hept-3-ene Chemical compound C1C2CC=C(C)[C@]1([H])C2(C)C GRWFGVWFFZKLTI-YGPZHTELSA-N 0.000 description 1
- JHEPBQHNVNUAFL-AATRIKPKSA-N (e)-hex-1-en-1-ol Chemical compound CCCC\C=C\O JHEPBQHNVNUAFL-AATRIKPKSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- MVOSYKNQRRHGKX-UHFFFAOYSA-N 11-Undecanolactone Chemical compound O=C1CCCCCCCCCCO1 MVOSYKNQRRHGKX-UHFFFAOYSA-N 0.000 description 1
- RWYRUDPAALLKPX-UHFFFAOYSA-N 2,2-difluoro-n-methylethanamine;hydrochloride Chemical compound Cl.CNCC(F)F RWYRUDPAALLKPX-UHFFFAOYSA-N 0.000 description 1
- HVNMCCPQUIEPCT-UHFFFAOYSA-N 2-(dimethylazaniumyl)pentanoate Chemical compound CCCC(N(C)C)C(O)=O HVNMCCPQUIEPCT-UHFFFAOYSA-N 0.000 description 1
- GNCOVOVCHIHPHP-UHFFFAOYSA-N 2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC(C(=C1)Cl)=CC=C1C(C=C1Cl)=CC=C1N=NC(C(C)=O)C(=O)NC1=CC=CC=C1 GNCOVOVCHIHPHP-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- CFAKWWQIUFSQFU-UHFFFAOYSA-N 2-hydroxy-3-methylcyclopent-2-en-1-one Chemical compound CC1=C(O)C(=O)CC1 CFAKWWQIUFSQFU-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical class O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- TWXUTZNBHUWMKJ-UHFFFAOYSA-N Allyl cyclohexylpropionate Chemical compound C=CCOC(=O)CCC1CCCCC1 TWXUTZNBHUWMKJ-UHFFFAOYSA-N 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000000120 Artificial Saliva Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
- 239000001749 Calcium fumarate Substances 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- APTGPWJUOYMUCE-UHFFFAOYSA-N S-Ethyl thioacetate Chemical compound CCSC(C)=O APTGPWJUOYMUCE-UHFFFAOYSA-N 0.000 description 1
- 102000001848 Salivary Proteins and Peptides Human genes 0.000 description 1
- 108010029987 Salivary Proteins and Peptides Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000862969 Stella Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010044032 Tooth discolouration Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 239000004301 calcium benzoate Substances 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 235000019255 calcium formate Nutrition 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 229940044172 calcium formate Drugs 0.000 description 1
- 235000019296 calcium fumarate Nutrition 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- BVTQVYBMHFSYPL-UHFFFAOYSA-L calcium;2-methylpropanoate Chemical compound [Ca+2].CC(C)C([O-])=O.CC(C)C([O-])=O BVTQVYBMHFSYPL-UHFFFAOYSA-L 0.000 description 1
- FYPVXEILSNEKOO-UHFFFAOYSA-L calcium;butanoate Chemical compound [Ca+2].CCCC([O-])=O.CCCC([O-])=O FYPVXEILSNEKOO-UHFFFAOYSA-L 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- YZLMERHFSCVBKZ-UHFFFAOYSA-L calcium;pentanoate Chemical compound [Ca+2].CCCCC([O-])=O.CCCCC([O-])=O YZLMERHFSCVBKZ-UHFFFAOYSA-L 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229940106705 chlorophyll Drugs 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 208000004042 dental fluorosis Diseases 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940070802 palmitoyl glutamate Drugs 0.000 description 1
- 239000007967 peppermint flavor Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- WBZFMJOAUABCPY-UHFFFAOYSA-N phenyl oxirane-2-carboxylate Chemical compound C1OC1C(=O)OC1=CC=CC=C1 WBZFMJOAUABCPY-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000003578 releasing effect Effects 0.000 description 1
- 230000000395 remineralizing effect Effects 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- AYGJDUHQRFKLBG-UHFFFAOYSA-M sodium;1,1-dioxo-1,2-benzothiazol-3-olate;dihydrate Chemical compound O.O.[Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 AYGJDUHQRFKLBG-UHFFFAOYSA-M 0.000 description 1
- SMKZBQZAMSKHNS-UHFFFAOYSA-M sodium;2-sulfoacetate Chemical compound [Na+].OS(=O)(=O)CC([O-])=O SMKZBQZAMSKHNS-UHFFFAOYSA-M 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、口腔内、特に口腔粘膜へのフッ素イオンの滞留性に優れ、かつその放出性にも優れるフッ素化合物含有の歯磨剤組成物に関する。 The present invention relates to a dentifrice composition containing a fluorine compound, which is excellent in the retention of fluorine ions in the oral cavity, particularly in the oral mucosa, and also in the release property thereof.
フッ化ナトリウム等のフッ素含有化合物は、再石灰化促進や脱灰抑制等の機能を有する薬用成分として、う蝕予防等の目的で歯磨剤組成物等の口腔用組成物に広く用いられている。フッ素含有化合物を効果的に作用させるには、フッ素イオンを長時間に亘って口腔内の歯面に滞留させることが有効であり、また、使用後に口腔内をうがいして水で漱ぐなどした後でも口腔内にフッ素イオンを多く残して留めておくことも重要であるが、特に歯磨剤組成物はブラッシング後の漱ぎによって洗い流されるため、口腔内に残存するフッ素イオンは微量に過ぎなかった。 Fluorine-containing compounds such as sodium fluoride are widely used in oral compositions such as dentifrice compositions for the purpose of preventing dental caries as medicinal components having functions such as promoting remineralization and suppressing decalcification. .. In order for the fluoride-containing compound to act effectively, it is effective to allow fluoride ions to stay on the tooth surface in the oral cavity for a long period of time, and after use, the oral cavity is gargled and rinsed with water. It is important to leave a large amount of fluoride ions in the oral cavity even afterwards, but in particular, since the dentifrice composition is washed away by rinsing after brushing, the amount of fluoride ions remaining in the oral cavity is only a small amount.
歯磨剤組成物に配合したフッ素イオンの口腔内滞留性を向上させるために、再石灰化成分であるカルシウムイオン、フッ素イオンを共存させる方法があるが、カルシウムイオンとフッ素イオンは反応性が高く、共存させると歯牙に対して作用する以前に不溶性物質であるフッ化カルシウムとなり、十分な効果を発揮させることができなかった。また、特許文献1(特表平10−511956号公報)では、カルシウムイオンとフッ素イオンを口腔内で又は口腔への適用直前に当該2つの組成物を混合することにより、口腔内でフッ化カルシウムを生成させる形態の口腔用剤が提案されているが、この方法では、フッ素イオンとして口腔内に入るため、すぐに唾液で流され、十分な滞留効果が発揮されず、また、2成分混合後に短時間でフッ化カルシウムが析出するため、フッ素イオンが十分に放出されず再石灰化予防効果が満足に発揮されなかった。特許文献2(特開2009−137863号公報)には、ポリリン酸塩、カルシウム塩、フッ化物塩の複合体を予め調製した組成物が提案されているが、この方法では調製面での煩雑さや歯磨製剤としての長期保存後に液状化や固化するなどの課題があった。
また、特許文献3〜5(特開2015−117215号公報、特開2013−67567号公報、特開2007−320894号公報)には、歯磨剤組成物において、特定のカチオン性高分子物質を用いた、歯面にフッ素イオンを吸着・滞留させる方法が提案されているが、その滞留性やブラッシング後の残存量には未だ改善の余地があり、更なる滞留性の向上が望まれた。
In order to improve the retention of fluoride ions in the dentifrice composition in the oral cavity, there is a method in which calcium ions and fluoride ions, which are remineralizing components, coexist, but calcium ions and fluoride ions are highly reactive and are highly reactive. When coexisted, it became calcium fluoride, which is an insoluble substance before it acted on the teeth, and it was not possible to exert a sufficient effect. Further, in Patent Document 1 (Japanese Patent Laid-Open No. 10-511956), calcium fluoride is calcium fluoride in the oral cavity by mixing the two compositions in the oral cavity or immediately before application to the oral cavity. However, in this method, since it enters the oral cavity as fluoride ions, it is immediately washed away by saliva, and a sufficient retention effect is not exhibited, and after mixing the two components, Since calcium fluoride was precipitated in a short time, fluorine ions were not sufficiently released and the effect of preventing remineralization was not satisfactorily exhibited. Patent Document 2 (Japanese Unexamined Patent Publication No. 2009-137863) proposes a composition in which a complex of a polyphosphate, a calcium salt, and a fluoride salt is prepared in advance, but this method is complicated in terms of preparation. There were problems such as liquefaction and solidification after long-term storage as a dentifrice preparation.
Further, in Patent Documents 3 to 5 (Japanese Patent Laid-Open Nos. 2015-117215, 2013-67567, 2007-320894), a specific cationic polymer substance is used in the dentifrice composition. However, a method of adsorbing and retaining fluorine ions on the tooth surface has been proposed, but there is still room for improvement in the retention property and the residual amount after brushing, and further improvement in the retention property is desired.
本発明は、上記事情に鑑みなされたもので、口腔内、特に口腔粘膜へのフッ素イオンの滞留性に優れ、その放出性にも優れる歯磨剤組成物を提供することを目的とする。 The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a dentifrice composition having excellent retention of fluoride ions in the oral cavity, particularly in the oral mucosa, and excellent release property thereof.
本発明者らは、上記目的を達成するため鋭意検討を行った結果、フッ化ナトリウムに、特定のポリリン酸塩及び水溶性カルシウム塩をそれぞれ特定量で併用し、更にカチオン化セルロースを組み合わせて歯磨剤組成物に配合すると、口腔内、特に口腔粘膜へのフッ素イオンの滞留性に優れ、フッ素イオンが高率で口腔内に滞留し、しかも、フッ素イオンの放出性(放出量、徐放性)に優れ、滞留したフッ素イオンが徐放し、長時間口腔内にフッ素イオンを供給でき、また、長期保存後も液分離及び固化が抑制され、良好な保存安定性となることを知見した。即ち、本発明では、(A)トリポリリン酸塩及びピロリン酸塩から選ばれる1種以上を0.1〜1.5質量%、(B)水溶性カルシウム塩を0.1〜1.5質量%、(C)フッ化ナトリウム、及び(D)カチオン化セルロースを配合した歯磨剤組成物が、口腔内、特に口腔粘膜へのフッ素イオンの滞留性に優れ、その放出性にも優れ、また、液分離安定性及び固化安定性を有し保存安定性も良いことを知見し、本発明をなすに至った。 As a result of diligent studies to achieve the above object, the present inventors have combined sodium fluoride with a specific polyphosphate and a water-soluble calcium salt in specific amounts, and further combined with cationized cellulose for toothpaste. When blended in the agent composition, it has excellent retention of fluoride ions in the oral cavity, especially in the oral mucosa, fluoride ions stay in the oral cavity at a high rate, and release of fluoride ions (release amount, sustained release). It was found that the retained fluoride ions were slowly released, the fluoride ions could be supplied to the oral cavity for a long period of time, and liquid separation and solidification were suppressed even after long-term storage, resulting in good storage stability. That is, in the present invention, one or more selected from (A) tripolyphosphate and pyrophosphate is 0.1 to 1.5% by mass, and (B) water-soluble calcium salt is 0.1 to 1.5% by mass. The dentifrice composition containing (C) sodium fluoride and (D) cationized cellulose has excellent retention of fluoride ions in the oral cavity, especially in the oral mucosa, and has excellent release property, and is also a liquid. It has been found that it has separation stability and solidification stability and has good storage stability, and has led to the present invention.
歯磨剤組成物に配合されたフッ素含有化合物のフッ素が、歯面だけでなく口腔粘膜にも十分に滞留すれば口腔内滞留性がより高まると期待されたが、口腔粘膜はムチン等の唾液タンパクで覆われているためにフッ素が吸着し難く、従来の技術では口腔粘膜にフッ素を十分に滞留させることができなかった。しかし、本発明では、(C)成分に、(A)及び(B)成分を併用し、かつ(D)成分を組み合わせることで、(A)成分量と(B)成分量とが特定範囲内で、(D)成分によって(C)成分由来のフッ素イオンの口腔粘膜への滞留性が改善し、フッ素イオンの滞留性だけでなくその放出性も優れたものとすることができた。この場合、(D)成分によって、口腔粘膜を覆っているムチンへのフッ素イオンの吸着性が高まることでその滞留性が改善し、フッ素イオンが高率で口腔粘膜に滞留し、しかも、滞留したフッ素イオンが徐々に唾液中に放出され、唾液と接する歯面に長時間供給される。したがって、本発明の歯磨剤組成物によれば、液分離安定性及び固化安定性を確保してフッ素イオンの口腔内滞留性を向上できる。 It was expected that the retention in the oral cavity would be further enhanced if the fluorine of the fluorine-containing compound contained in the dentin composition sufficiently retained not only on the tooth surface but also on the oral mucosa, but the oral mucosa is a salivary protein such as mucin. Since it is covered with mucin, it is difficult for fluorine to be adsorbed, and it was not possible to sufficiently retain fluorine in the oral mucosa by the conventional technique. However, in the present invention, by using the components (A) and (B) in combination with the component (C) and combining the components (D), the amount of the component (A) and the amount of the component (B) are within a specific range. Therefore, the retention of fluoride ions derived from the component (C) in the oral mucosa was improved by the component (D), and it was possible to improve not only the retention of fluoride ions but also the release property thereof. In this case, the component (D) enhances the adsorptivity of fluoride ions to the mucin covering the oral mucosa, thereby improving the retention of fluoride ions, and the fluoride ions stay in the oral mucosa at a high rate. Fluoride ions are gradually released into saliva and supplied to the tooth surface in contact with saliva for a long time. Therefore, according to the dentifrice composition of the present invention, it is possible to secure liquid separation stability and solidification stability and improve the retention of fluoride ions in the oral cavity.
後述の比較例に示すように、(A)、(B)及び(C)成分が配合され、(D)成分が配合されていないと、フッ素(フッ素イオン)滞留性及びフッ素放出性、製剤の液分離安定性が悪く(比較例5)、また、(D)成分が配合されていても、(A)成分量又は(B)成分量が不適切であると、フッ素滞留性及びフッ素放出性が悪かった(比較例1〜4)。これに対して、本発明の特定量の(A)及び(B)成分、(C)成分、(D)成分が配合された歯磨剤組成物(後述の実施例)は、フッ素滞留性及びフッ素放出性が優れ、製剤の液分離安定性(保存後の液分離のなさ)及び固化安定性(保存後の固化のなさ)が良好であった。 As shown in the comparative example described later, if the components (A), (B) and (C) are blended and the component (D) is not blended, fluorine (fluorine ion) retention and fluorine release property, and the pharmaceutical product Liquid separation stability is poor (Comparative Example 5), and even if the component (D) is blended, if the amount of the component (A) or the amount of the component (B) is inappropriate, the fluorine retention and the fluorine release property Was bad (Comparative Examples 1 to 4). On the other hand, the dentifrice composition (Examples described later) containing a specific amount of the components (A) and (B), (C) and (D) of the present invention has fluorine retention and fluorine. The release property was excellent, and the liquid separation stability (no liquid separation after storage) and solidification stability (no solidification after storage) of the preparation were good.
従って、本発明は、下記の歯磨剤組成物を提供する。
〔1〕
(A)トリポリリン酸塩及びピロリン酸塩から選ばれる1種以上を0.1〜1.5質量%、
(B)水溶性カルシウム塩を0.1〜1.5質量%、
(C)フッ化ナトリウム
及び
(D)カチオン化セルロース
を含有することを特徴とする歯磨剤組成物。
〔2〕
(A)成分が、ピロリン酸カリウムである〔1〕に記載の歯磨剤組成物。
〔3〕
(B)水溶性カルシウム塩が、塩化カルシウムである〔1〕又は〔2〕に記載の歯磨剤組成物。
〔4〕
(A)/(C)が、モル比として0.05〜1である〔1〕〜〔3〕のいずれかに記載の歯磨剤組成物。
〔5〕
(B)/(C)が、モル比として0.1〜2である〔1〕〜〔4〕のいずれかに記載の歯磨剤組成物。
〔6〕
(C)成分の含有量が0.11〜1.1質量%である〔1〕〜〔5〕のいずれかに記載の歯磨剤組成物。
〔7〕
(D)成分の含有量が0.01〜0.5質量%である〔1〕〜〔6〕のいずれかに記載の歯磨剤組成物。
〔8〕
練歯磨剤組成物である〔1〕〜〔7〕のいずれかに記載の歯磨剤組成物。
Therefore, the present invention provides the following dentifrice compositions.
[1]
(A) 0.1 to 1.5% by mass of one or more selected from tripolyphosphate and pyrophosphate.
(B) 0.1 to 1.5% by mass of water-soluble calcium salt,
A dentifrice composition comprising (C) sodium fluoride and (D) cationized cellulose.
[2]
The dentifrice composition according to [1], wherein the component (A) is potassium pyrophosphate.
[3]
(B) The dentifrice composition according to [1] or [2], wherein the water-soluble calcium salt is calcium chloride.
[4]
The dentifrice composition according to any one of [1] to [3], wherein (A) / (C) has a molar ratio of 0.05 to 1.
[5]
The dentifrice composition according to any one of [1] to [4], wherein (B) / (C) has a molar ratio of 0.1 to 2.
[6]
The dentifrice composition according to any one of [1] to [5], wherein the content of the component (C) is 0.11 to 1.1% by mass.
[7]
The dentifrice composition according to any one of [1] to [6], wherein the content of the component (D) is 0.01 to 0.5% by mass.
[8]
The dentifrice composition according to any one of [1] to [7], which is a dentifrice composition.
本発明によれば、口腔内、特に口腔粘膜へのフッ素イオンの滞留性に優れ、その放出性にも優れ、また、液分離安定性及び固化安定性を有し保存安定性も良い歯磨剤組成物を提供できる。本発明の歯磨剤組成物は、口腔内をブラッシング後にうがいして水で漱いだ後でもフッ素イオンを比較的多く口腔内に残して留めておくことができ、フッ素含有化合物の再石灰化促進、脱灰抑制等の効果を十分に発揮させることもでき、う蝕予防用として好適である。 According to the present invention, a dentifrice composition having excellent retention of fluoride ions in the oral cavity, particularly in the oral mucosa, excellent release property thereof, liquid separation stability and solidification stability, and good storage stability. Can provide things. The dentifrice composition of the present invention can retain a relatively large amount of fluoride ions in the oral cavity even after gargle and rinse with water after brushing the oral cavity, and promote remineralization of the fluoride-containing compound. , It is also possible to fully exert effects such as decalcification suppression, and it is suitable for caries prevention.
以下、本発明につき更に詳述する。本発明の歯磨剤組成物は、(A)トリポリリン酸塩及びピロリン酸塩から選ばれる1種以上、(B)水溶性カルシウム塩、(C)フッ化ナトリウム、及び(D)カチオン化セルロースを含有する。 Hereinafter, the present invention will be described in more detail. The dentifrice composition of the present invention contains (A) one or more selected from tripolyphosphate and pyrophosphate, (B) water-soluble calcium salt, (C) sodium fluoride, and (D) cationized cellulose. To do.
(A)成分は、ポリリン酸塩のトリポリリン酸塩、ピロリン酸塩である。(A)成分は、フッ素イオンの滞留性の向上作用を奏し、また、液分離抑制作用を奏する。
(A)成分は、トリポリリン酸、ピロリン酸のカリウム塩、ナトリウム塩等のアルカリ金属塩を使用でき、中でもピロリン酸カリウムが好ましい。これらは1種単独でも2種以上を併用してもよい。
The component (A) is a polyphosphate tripolyphosphate or pyrophosphate. The component (A) has an effect of improving the retention of fluorine ions and an effect of suppressing liquid separation.
As the component (A), alkali metal salts such as tripoliphosphoric acid, potassium salt of pyrophosphoric acid, and sodium salt can be used, and potassium pyrophosphate is particularly preferable. These may be used alone or in combination of two or more.
(A)成分の配合量は、組成物全体の0.1〜1.5%(質量%、以下同様)であり、好ましくは0.15〜1.4%、より好ましくは0.3〜1.0%である。配合量が0.1%未満であると、フッ素イオンの滞留性及びその放出性が劣り、また、経時で液分離が生じて液分離安定性に劣る。1.5%を超えると、フッ素イオンの滞留性及びその放出性が低下し、経時で固化が生じ固化安定性に劣る。 The blending amount of the component (A) is 0.1 to 1.5% (mass%, the same applies hereinafter) of the entire composition, preferably 0.15 to 1.4%, and more preferably 0.3 to 1. It is 0.0%. If the blending amount is less than 0.1%, the retention and release of fluorine ions are inferior, and liquid separation occurs over time, resulting in inferior liquid separation stability. If it exceeds 1.5%, the retention and release of fluorine ions are lowered, and solidification occurs over time, resulting in poor solidification stability.
(B)水溶性カルシウム塩は、フッ素イオンの滞留性の向上作用を奏し、また、固化抑制作用を奏する。
水溶性カルシウム塩は、例えば塩化カルシウム、硝酸カルシウム、酢酸カルシウム、クエン酸カルシウム、グルコン酸カルシウム、安息香酸カルシウム、ギ酸カルシウム、フマル酸カルシウム、乳酸カルシウム、酪酸カルシウム及びイソ酪酸カルシウム、リンゴ酸カルシウム、マレイン酸カルシウム、プロピロン酸カルシウム、吉草酸カルシウム等が挙げられ、特に塩化カルシウムが好ましい。
(B) The water-soluble calcium salt has an effect of improving the retention of fluoride ions and an effect of suppressing solidification.
Water-soluble calcium salts include, for example, calcium chloride, calcium nitrate, calcium acetate, calcium citrate, calcium gluconate, calcium benzoate, calcium formate, calcium fumarate, calcium lactate, calcium butyrate and calcium isobutyrate, calcium malate, malein. Calcium acid, calcium propyronate, calcium valerate and the like can be mentioned, and calcium chloride is particularly preferable.
(B)水溶性カルシウム塩の配合量は、組成物全体の0.1〜1.5%であり、好ましくは0.1〜0.7%、より好ましくは0.3〜0.7%である。配合量が0.1%未満であると、フッ素イオンの滞留性及びその放出性が劣り、また、経時で固化し易くなり、固化安定性に劣る。1.5%を超えると、フッ素イオンの滞留性及びその放出性が劣り、また、経時で液分離が生じて液分離安定性に劣る。 The amount of the water-soluble calcium salt (B) blended is 0.1 to 1.5% of the entire composition, preferably 0.1 to 0.7%, and more preferably 0.3 to 0.7%. is there. If the blending amount is less than 0.1%, the retention of fluorine ions and their release property are inferior, and they are easily solidified with time, and the solidification stability is inferior. If it exceeds 1.5%, the retention and release of fluorine ions are inferior, and liquid separation occurs over time, resulting in inferior liquid separation stability.
(C)フッ化ナトリウムの配合量は、組成物全体の0.11〜1.1%が好ましく、より好ましくは0.32〜0.66%である。配合量が0.11%以上であると、フッ素イオンの滞留性の向上効果が十分に得られる。1.1%以下であると、過剰摂取による斑状歯等の為害作用の発生を十分に防止できる。 The blending amount of sodium fluoride (C) is preferably 0.11 to 1.1%, more preferably 0.32 to 0.66% of the total composition. When the blending amount is 0.11% or more, the effect of improving the retention of fluorine ions can be sufficiently obtained. When it is 1.1% or less, it is possible to sufficiently prevent the occurrence of harmful effects such as mottled teeth due to excessive intake.
本発明では、(A)成分と(C)成分との量比を示す(A)/(C)が、モル比として好ましくは0.05〜1、より好ましくは0.1〜0.5、特に0.10〜0.50である。また、(B)成分と(C)成分との量比を示す(B)/(C)が、モル比として好ましくは0.1〜2、より好ましくは0.3〜1である。(A)/(C)のモル比、(B)/(C)のモル比がそれぞれ上記範囲内であると、更に好ましい。これらモル比の範囲内で(C)成分を配合すると、フッ素イオンの滞留性及びその放出性がより優れ、また、液分離安定性及び固化安定性がより優れる。 In the present invention, (A) / (C), which indicates the amount ratio of the component (A) to the component (C), is preferably 0.05 to 1, more preferably 0.1 to 0.5, as a molar ratio. In particular, it is 0.10 to 0.50. Further, (B) / (C), which indicates the quantitative ratio of the component (B) to the component (C), is preferably 0.1 to 2, more preferably 0.3 to 1, as a molar ratio. It is more preferable that the molar ratio of (A) / (C) and the molar ratio of (B) / (C) are within the above ranges, respectively. When the component (C) is blended within these molar ratios, the retention and release of fluorine ions are more excellent, and the liquid separation stability and solidification stability are more excellent.
(D)カチオン化セルロースは、(B)及び(C)成分と組み合わせることで、(C)成分由来のフッ素イオンの滞留性を向上し、かつその放出性を改善する作用を奏し、また、液分離安定性を改善する作用を奏する。 When the cationized cellulose (D) is combined with the components (B) and (C), it has an effect of improving the retention of fluorine ions derived from the component (C) and improving the release property thereof, and also a liquid. It has the effect of improving separation stability.
カチオン化セルロースは、カチオンを有するセルロース、又はカチオンを有するセルロース誘導体である。カチオン化セルロースは、対イオン(例えばハロゲンイオン(塩素イオン)、メトサルフェートイオン等)を有していてもよい。カチオン化セルロースの分子量は特に限定されない。(D)成分として、カチオン化セルロースは1種を単独で用いてもよいし、2種以上を組み合わせて用いてもよい。
カチオン化セルロースの例としては、ヒドロキシエチルセルロースジメチルジアリルアンモニウム塩、塩化O−[2−ヒドロキシ−3−(トリメチルアンモニオ)プロピル]ヒドロキシエチルセルロースが挙げられ、好ましくはヒドロキシエチルセルロースジメチルジアリルアンモニウム塩である。
ヒドロキシエチルセルロースジメチルジアリルアンモニウム塩は、対イオンとしては塩化物イオンが挙げられ、ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリドが好適である。
本発明で用いるカチオン化セルロースは、その2%水溶液粘度(BH型ブルックフィールド粘度計、ローターNo.2、20回転、20℃、測定時間1分)が30〜3,000mPa・sであることが好ましい。
カチオン化セルロースの平均分子量は、特に限定されないが、ポリエチレングリコールを標準物質としたゲルパーミエーションクロマトグラフ(GPC)法による重量平均分子量で、好ましくは100,000〜1,500,000である。窒素含有量としては0.1〜3%が好ましく、より好ましくは0.5〜2.5%である。
このようなカチオン化セルロースとしては、例えば、アクゾノーベル(株)から市販されているCELQUAT L−200(2%粘度:35〜350mPa・s、BH型ブルックフィールド粘度計、ローターNo.2、20回転、20℃、測定時間1分)、ポリエチレングリコールを標準物質としたゲルパーミエーションクロマトグラフ(GPC)法による重量平均分子量:250,000〜350,000)が挙げられ、使用できる。
The cationized cellulose is a cellulose having a cation or a cellulose derivative having a cation. The cationized cellulose may have a counter ion (for example, a halogen ion (chlorine ion), a metosulfate ion, etc.). The molecular weight of the cationized cellulose is not particularly limited. As the component (D), one type of cationized cellulose may be used alone, or two or more types may be used in combination.
Examples of the cationized cellulose include hydroxyethyl cellulose dimethyldiallylammonium salt and O- [2-hydroxy-3- (trimethylammonio) propyl] hydroxyethyl cellulose chloride, and hydroxyethyl cellulose dimethyldiallylammonium salt is preferable.
As the hydroxyethyl cellulose dimethyl diallyl ammonium salt, chloride ion is mentioned as a counter ion, and hydroxyethyl cellulose dimethyl diallyl ammonium chloride is preferable.
The cationized cellulose used in the present invention has a 2% aqueous solution viscosity (BH type Brookfield viscometer, rotor No. 2, 20 rotations, 20 ° C., measurement time 1 minute) of 30 to 3,000 mPa · s. preferable.
The average molecular weight of the cationized cellulose is not particularly limited, but is a weight average molecular weight by the gel permeation chromatography (GPC) method using polyethylene glycol as a standard substance, and is preferably 100,000 to 1,500,000. The nitrogen content is preferably 0.1 to 3%, more preferably 0.5 to 2.5%.
Examples of such cationized cellulose include CELQUAT L-200 (2% viscosity: 35 to 350 mPa · s, BH type Brookfield viscometer, rotor No. 2, 20 rotations) commercially available from Axonobel Co., Ltd. , 20 ° C., measurement time 1 minute), weight average molecular weight by gel permeation chromatography (GPC) method using polyethylene glycol as a standard substance: 250,000 to 350,000), and can be used.
(D)成分の配合量は、組成物全体の0.01〜0.5%が好ましく、より好ましくは0.05〜0.2%である。0.01%以上配合すると、フッ素イオンの滞留性及びその放出性が十分に得られ、また、経時でも液分離が抑制され十分な液分離安定性が得られる。0.5%以下であると、口腔粘膜への違和感が十分に抑制される。 The blending amount of the component (D) is preferably 0.01 to 0.5%, more preferably 0.05 to 0.2% of the entire composition. When 0.01% or more is blended, the retention of fluorine ions and the release property thereof can be sufficiently obtained, and the liquid separation is suppressed even with time, and sufficient liquid separation stability can be obtained. When it is 0.5% or less, the discomfort to the oral mucosa is sufficiently suppressed.
また、(A)成分と(D)成分との量比を示す(A)/(D)は、質量比として1〜50が好ましく、より好ましくは3〜25である。また、(B)成分と(D)成分との量比を示す(B)/(D)は、質量比として1〜50が好ましく、より好ましくは2〜20であり、(C)成分と(D)成分との量比を示す(C)/(D)は、質量比として1〜20が好ましく、より好ましくは1〜10である。これら質量比の範囲内で(D)成分を配合すると、(D)成分による効果が十分に発揮され、フッ素イオンの滞留性及びその放出性がより優れ、また、液分離安定性がより優れる。 Further, (A) / (D) indicating the quantitative ratio of the component (A) to the component (D) is preferably 1 to 50, more preferably 3 to 25, as a mass ratio. Further, (B) / (D) indicating the quantitative ratio of the component (B) and the component (D) is preferably 1 to 50, more preferably 2 to 20 as a mass ratio, and the component (C) and (C). As for (C) / (D) indicating the amount ratio with the component D), the mass ratio is preferably 1 to 20, more preferably 1 to 10. When the component (D) is blended within the range of these mass ratios, the effect of the component (D) is sufficiently exhibited, the retention and release of fluorine ions are more excellent, and the liquid separation stability is more excellent.
本発明の歯磨剤組成物は、特に練歯磨剤組成物として好適であり、また、上記成分に加えて、その他の公知成分を本発明の効果を妨げない範囲で必要に応じて配合できる。例えば、研磨剤、粘結剤、粘稠剤、界面活性剤、更に必要により着色剤、甘味料、防腐剤、香料、有効成分等を配合できる。なお、歯磨剤組成物の調製方法は、特に限定されず、剤型に応じた公知の方法でよく、例えば、(A)〜(D)成分、更には任意成分、水を通常の方法で配合し、調製できる。 The dentifrice composition of the present invention is particularly suitable as a dentifrice composition, and in addition to the above components, other known components can be blended as necessary within a range that does not interfere with the effects of the present invention. For example, an abrasive, a binder, a thickener, a surfactant, and if necessary, a colorant, a sweetener, a preservative, a flavor, an active ingredient, and the like can be blended. The method for preparing the dentifrice composition is not particularly limited, and a known method depending on the dosage form may be used. For example, the components (A) to (D), further, any component, and water are blended by a usual method. And can be prepared.
研磨剤は、例えば無水ケイ酸、沈降性シリカ、シリカゲル、アルミノシリケート、ジルコノシリケート等のシリカ系研磨剤、第2リン酸カルシウム・2水和物又は無水和物、第1リン酸カルシウム、第3リン酸カルシウム、第4リン酸カルシウム、ピロリン酸カルシウム等のリン酸カルシウム系化合物、炭酸カルシウム、水酸化カルシウム、水酸化アルミニウム、不溶性メタリン酸ナトリウム、第3リン酸マグネシウム、炭酸マグネシウム、硫酸カルシウム、ベントナイト、チタニウム結合ケイ酸塩、合成樹脂系研磨剤が挙げられる。中でも、シリカ系研磨剤が好ましい。
研磨剤の配合量は、組成物全体の5〜60%、特に5〜30%が好ましい。
The polishing agent is, for example, a silica-based polishing agent such as silicic anhydride, precipitated silica, silica gel, aluminosilicate, zirconosilicate, calcium dibasic phosphate / dihydrate or anhydride, calcium phosphate 1st, calcium phosphate 3rd, and the like. 4 Calcium phosphate compounds such as calcium phosphate and calcium pyrophosphate, calcium carbonate, calcium hydroxide, aluminum hydroxide, insoluble sodium metaphosphate, tertiary magnesium phosphate, magnesium carbonate, calcium sulfate, bentonite, titanium-bonded silicate, synthetic resin Polishing agents can be mentioned. Of these, silica-based abrasives are preferable.
The blending amount of the abrasive is preferably 5 to 60%, particularly 5 to 30% of the total composition.
粘結剤は、有機又は無機粘結剤を配合できる。具体的には、カルボキシメチルセルロースナトリウム、メチルセルロース、ヒドロキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシメチルエチルセルロース等のセルロース誘導体、アルギン酸ナトリウム等のアルギン酸誘導体、キサンタンガム、トラガカントガム、カラヤガム、アラビアガム等のガム類、カラギーナン、ポリビニルアルコール、カルボキシビニルポリマーといった有機粘結剤、増粘性シリカ、増粘性アルミニウムシリカ、ビーガム、ラポナイト等の無機粘結剤が挙げられる。
粘結剤の配合量は、組成物全体の0.2〜3%が好ましい。なお、本発明では、特に有機粘結剤が好ましく、有機粘結剤の配合量は、組成物全体の0.1〜5%、特に0.5〜3%がよい。無機粘結剤、特に増粘性シリカは、フッ素イオンの滞留性の点で、配合する場合は組成物全体の5%以下、特に2%以下、とりわけ1%以下が好ましく、配合せず0%でもよい。
As the binder, an organic or inorganic binder can be blended. Specifically, cellulose derivatives such as sodium carboxymethyl cellulose, methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, hydroxymethyl ethyl cellulose, alginate derivatives such as sodium alginate, xanthan gum, tragacant gum, carrageenan gum, Arabic gum and the like. Examples include organic binders such as gums, carrageenan, polyvinyl alcohol and carboxyvinyl polymers, and inorganic binders such as thickening silica, thickening aluminum silica, bee gum and laponite.
The blending amount of the binder is preferably 0.2 to 3% of the total composition. In the present invention, an organic binder is particularly preferable, and the blending amount of the organic binder is preferably 0.1 to 5%, particularly 0.5 to 3% of the entire composition. Inorganic binders, especially thickening silica, are preferably 5% or less, particularly 2% or less, particularly 1% or less of the entire composition when blended in terms of the retention of fluorine ions, and even 0% without blending. Good.
粘稠剤は、ソルビット、キシリット、エリスリトール、マルチット、ラクチット等の糖アルコール、グリセリン、プロピレングリコール、平均分子量160〜400(医薬部外品原料規格2006記載の平均分子量)のポリエチレングリコール等の多価アルコールが挙げられる。粘稠剤の配合量は、通常、組成物全体の5〜60%がよい。 The viscous agent includes sugar alcohols such as sorbitol, xylit, erythritol, martit, and lacchit, and polyhydric alcohols such as glycerin, propylene glycol, and polyethylene glycol having an average molecular weight of 160 to 400 (average molecular weight described in the raw material standard for non-pharmaceutical products 2006). Can be mentioned. The blending amount of the thickener is usually 5 to 60% of the total composition.
界面活性剤は、アニオン性界面活性剤、ノニオン性界面活性剤、両性界面活性剤を配合することができる。
アニオン性界面活性剤は、ラウリル硫酸ナトリウム、ミリスチル硫酸ナトリウム等のアルキル硫酸塩、ラウロイルサルコシンナトリウム、ミリストイルサルコシンナトリウム等のアシルサルコシン酸塩、ドデシルベンゼンスルホン酸ナトリウム、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウムや、N−パルミトイルグルタミン酸ナトリウム等のアシルグルタミン酸塩、N−メチル−N−アシルタウリンナトリウム、N−メチル−N−アシルアラニンナトリウム、α−オレフィンスルホン酸ナトリウムが挙げられる。
ノニオン性界面活性剤は、ポリオキシエチレンアルキルエーテル(例えばアルキル基の炭素数が16〜18のもの)、ポリオキシエチレン硬化ヒマシ油(例えばエチレンオキサイドの平均付加モル数が40〜80のもの)、アルキルグルコシド、ポリオキシエチレンポリオキシプロピレンブロック共重合体、ポリグリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、アルキロールアマイド、ポリオキシエチレンソルビタンモノステアレート、ポリオキシエチレンポリオキシプロピレングリコール等が挙げられる。
両性界面活性剤は、ラウリルジメチルアミノ酢酸ベタイン、N−ヤシ油脂肪酸アシル−N−カルボキシメチル−N−ヒドロキシエチルエチレンジアミン、ヤシ油脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン、ヤシ油脂肪酸アミドプロピル等が挙げられる。
界面活性剤の配合量は、通常、組成物全体の0.1〜10%がよい。配合量は、歯磨剤組成物の形態、使用目的等に応じ調整でき、例えば、練歯磨には0.1〜10%配合することができる。
As the surfactant, an anionic surfactant, a nonionic surfactant, and an amphoteric surfactant can be blended.
Anionic surfactants include alkyl sulfates such as sodium lauryl sulfate and sodium myristyl sulfate, acyl sarcosates such as sodium lauroyl sarcosin and sodium myristyl sarcosin, sodium dodecylbenzene sulfonate, hydrogenated coconut fatty acid monoglyceride monoglyceride sodium monosulfate, and lauryl. Examples thereof include sodium sulfoacetate, acyl glutamate such as sodium N-palmitoyl glutamate, sodium N-methyl-N-acyl taurine, sodium N-methyl-N-acylalanine, and sodium α-olefin sulfonate.
Nonionic surfactants include polyoxyethylene alkyl ethers (for example, those having an alkyl group having 16 to 18 carbon atoms), polyoxyethylene hydrogenated castor oil (for example, those having an average number of moles of ethylene oxide added of 40 to 80), and the like. Alkyl glucoside, polyoxyethylene polyoxypropylene block copolymer, polyglycerin fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, alkylol amide, polyoxyethylene sorbitan monostearate, polyoxyethylene polyoxypropylene glycol, etc. Be done.
Examples of the amphoteric surfactant include betaine lauryldimethylaminoacetate, acyl-N-carboxymethyl-N-hydroxyethylethylenediamine of N-palm oil fatty acid, betaine amide propyl dimethylaminoacetic acid of coconut oil, and amide propyl of coconut oil fatty acid.
The blending amount of the surfactant is usually preferably 0.1 to 10% of the total composition. The blending amount can be adjusted according to the form of the dentifrice composition, the purpose of use, etc. For example, 0.1 to 10% can be blended in dentifrice.
着色剤は、赤色2号、赤色3号、赤色225号、赤色226号、黄色4号、黄色5号、黄色205号、青色1号、青色2号、青色201号、青色204号、緑色3号、雲母チタン、酸化チタン等が挙げられる。
甘味料は、サッカリンナトリウム、アスパルテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジンジヒドロカルコン、ペリラルチン等が挙げられる。
防腐剤は、メチルパラベン、エチルパラベン、ブチルパラベン等のパラオキシ安息香酸エステル、安息香酸ナトリウム等の安息香酸又はその塩が挙げられる。
The colorants are Red No. 2, Red No. 3, Red No. 225, Red No. 226, Yellow No. 4, Yellow No. 5, Yellow No. 205, Blue No. 1, Blue No. 2, Blue No. 201, Blue No. 204, Green No. 3 No., mica titanium, titanium oxide and the like.
Examples of the sweetener include sodium saccharin, aspartame, stebioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine and the like.
Examples of the preservative include paraoxybenzoic acid esters such as methylparaben, ethylparaben and butylparaben, benzoic acid such as sodium benzoate, or salts thereof.
香料は、ペパーミント油、スペアミント油、アニス油、ユーカリ油、ウィンターグリーン油、カシア油、クローブ油、タイム油、セージ油、レモン油、オレンジ油、ハッカ油、カルダモン油、コリアンダー油、マンダリン油、ライム油、ラベンダー油、ローズマリー油、ローレル油、カモミル油、キャラウェイ油、マジョラム油、ベイ油、レモングラス油、オリガナム油、パインニードル油、ネロリ油、ローズ油、ジャスミン油、グレープフルーツ油、スウィーティー油、柚油、イリスコンクリート、アブソリュートペパーミント、アブソリュートローズ、オレンジフラワー等の天然香料や、これら天然香料の加工処理(前溜部カット、後溜部カット、分留、液液抽出、エッセンス化、粉末香料化等)した香料、及び、メントール、カルボン、アネトール、シネオール、サリチル酸メチル、シンナミックアルデヒド、オイゲノール、3−l−メントキシプロパン−1,2−ジオール、チモール、リナロール、リナリールアセテート、リモネン、メントン、メンチルアセテート、N−置換−パラメンタン−3−カルボキサミド、ピネン、オクチルアルデヒド、シトラール、プレゴン、カルビールアセテート、アニスアルデヒド、エチルアセテート、エチルブチレート、アリルシクロヘキサンプロピオネート、メチルアンスラニレート、エチルメチルフェニルグリシデート、バニリン、ウンデカラクトン、ヘキサナール、ブタノール、イソアミルアルコール、ヘキセノール、ジメチルサルファイド、シクロテン、フルフラール、トリメチルピラジン、エチルラクテート、エチルチオアセテート等の単品香料、更に、ストロベリーフレーバー、アップルフレーバー、バナナフレーバー、パイナップルフレーバー、グレープフレーバー、マンゴーフレーバー、バターフレーバー、ミルクフレーバー、フルーツミックスフレーバー、トロピカルフルーツフレーバー等の調合香料等、歯磨剤組成物に用いられる公知の香料素材を組み合わせて使用することができる。
また、配合量も特に限定されないが、上記の香料素材は、製剤組成中に0.000001〜1%使用することが好ましい。また、上記香料素材を使用した賦香用香料としては、製剤組成中に0.05〜2%使用することが好ましい。
Fragrances are peppermint oil, sparemint oil, anis oil, eucalyptus oil, winter green oil, cassia oil, clove oil, thyme oil, sage oil, lemon oil, orange oil, peppermint oil, cardamon oil, coriander oil, mandarin oil, lime. Oil, lavender oil, rosemary oil, laurel oil, camomill oil, caraway oil, majorum oil, bay oil, lemongrass oil, origanum oil, pine needle oil, neroli oil, rose oil, jasmine oil, grapefruit oil, sweetie oil , Yuzu oil, iris concrete, absolute peppermint, absolute rose, orange flower and other natural fragrances, and processing of these natural fragrances (pre-reservoir cut, rear-reservoir cut, distilling, liquid extraction, essence, powder fragrance Perfume, menthol, carboxylic, anator, cineole, methyl salicylate, synamic aldehyde, eugenol, 3-l-mentoxypropane-1,2-diol, timole, linalol, linaryl acetate, limonene, menton , Menthylacetate, N-substituted-paramentan-3-carboxamide, pinen, octylaldehyde, citral, pregon, calvier acetate, anisaldehyde, ethylacetate, ethylbutyrate, allylcyclohexanepropionate, methylanthranilate, ethylmethyl Single flavors such as phenylglycidate, vanillin, undecalactone, hexanal, butanol, isoamyl alcohol, hexenol, dimethylsulfide, cycloten, furfural, trimethylpyrazine, ethyllactate, ethylthioacetate, strawberry flavor, apple flavor, banana flavor , Peppermint flavor, grape flavor, mango flavor, butter flavor, milk flavor, fruit mix flavor, tropical fruit flavor and other blended flavors, and other known flavoring materials used in toothpaste compositions can be used in combination.
Further, the blending amount is not particularly limited, but it is preferable to use 0.000001 to 1% of the above-mentioned fragrance material in the formulation composition. Further, as a fragrance for fragrance using the above fragrance material, it is preferable to use 0.05 to 2% in the composition of the preparation.
有効成分としては、イソプロピルメチルフェノール、塩化セチルピリジニウム等の殺菌剤、正リン酸のカリウム塩、ナトリウム塩等の水溶性リン酸化合物、デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ等の酵素、トラネキサム酸、イプシロンアミノカプロン酸、トリクロサン、塩化リゾチーム、アルミニウムクロルヒドロキシアラントイン、ヒノキチオール、アスコルビン酸、酢酸トコフェロール、ジヒドロコレステロール、α−ビサボロール、クロルヘキシジン塩類、アズレンや、銅クロロフィリンナトリウム、クロロフィル、グルコン酸銅等の水溶性銅化合物、乳酸アルミニウム、塩化ストロンチウム、硝酸カリウム、ベルベリン、ヒドロキサム酸又はその誘導体、グルチルリチン酸又はその塩、グリチルレチン酸又はその誘導体、歯石防止剤が挙げられる。なお、上記有効成分は、本発明の効果を妨げない範囲で有効量配合することができる。 As active ingredients, bactericides such as isopropylmethylphenol and cetylpyridinium chloride, water-soluble phosphoric acid compounds such as potassium salt of orthophosphate and sodium salt, enzymes such as dextranase, mutanase, amylases and protease, tranexamic acid, etc. Water-soluble copper compounds such as epsilon aminocaproic acid, triclosan, lysozyme chloride, aluminum chlorohydroxyalantin, hinokithiol, ascorbic acid, tocopherol acetate, dihydrocholesterol, α-bisabolol, chlorhexidine salts, azulene, sodium copper chlorophyllin, chlorophyll, copper gluconate, etc. , Aluminum lactate, strontium chloride, potassium nitrate, velverin, hydroxamic acid or a derivative thereof, glutyllithic acid or a salt thereof, glycyrrhetinic acid or a derivative thereof, and an anti-dental stone agent. The active ingredient can be blended in an effective amount within a range that does not interfere with the effects of the present invention.
以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。なお、下記の例において%は特に断らない限りいずれも質量%を示す。 Hereinafter, the present invention will be specifically described with reference to Examples and Comparative Examples, but the present invention is not limited to the following Examples. In the following examples,% indicates mass% unless otherwise specified.
[実施例、比較例]
表1〜3に示す組成の歯磨剤組成物(練歯磨)を常法によって調製し、下記方法で評価した。結果を表に併記した。
[Examples, comparative examples]
Toothpaste compositions (dentifrices) having the compositions shown in Tables 1 to 3 were prepared by a conventional method and evaluated by the following methods. The results are also shown in the table.
(1)フッ素(フッ素イオン)滞留性の評価方法
フッ素(フッ素イオン)の口腔粘膜成分であるムチンへの吸着性試験により、フッ素イオンの滞留性を評価した。
10mL遠心チューブにムチン(Sigma−Aldrich社製)を0.2g添加し、更に歯磨剤組成物(精製水による40倍希釈液)を5mL加え、3分間作用させた。その後、3,000rpmで10分間遠心分離し、上清を除去した。得られたムチンに、クエン酸カリウム緩衝液を5mL加えて1分間撹拌し、ムチンに吸着・滞留したフッ素イオンを強制的に溶出させた。3,000rpmで10分間遠心分離して上清を回収し、溶液に含まれるフッ素(フッ素イオン)濃度をフッ素イオンメーター(Orion 1115000 4−Star:サーモフィッシャーサイエンティフィック(株)製)で測定し、滞留フッ素イオン濃度(ppm)を得た。
フッ素イオン滞留率を以下の式により算出した。
フッ素イオン滞留率(%)=
{(滞留フッ素イオン濃度(ppm))/(製剤に配合したフッ素イオン濃度(ppm)/40)}×100
フッ素イオン滞留率から、下記の評価基準でフッ素イオン滞留性を評価した。
評価基準
◎:フッ素イオン滞留率が50%以上
〇:フッ素イオン滞留率が30%以上50%未満
△:フッ素イオン滞留率が20%以上30%未満
×:フッ素イオン滞留率が20%未満
(1) Evaluation method of fluorine (fluoride ion) retention The retention of fluorine ions was evaluated by an adsorption test of fluorine (fluoride ion) to mucin, which is an oral mucosal component.
0.2 g of mucin (manufactured by Sigma-Aldrich) was added to a 10 mL centrifuge tube, and 5 mL of a dentifrice composition (40-fold diluted solution with purified water) was further added and allowed to act for 3 minutes. Then, the mixture was centrifuged at 3,000 rpm for 10 minutes to remove the supernatant. To the obtained mucin, 5 mL of potassium citrate buffer was added and stirred for 1 minute to forcibly elute the fluoride ions adsorbed and retained on the mucin. Centrifuge at 3,000 rpm for 10 minutes to collect the supernatant, and measure the concentration of fluorine (fluoride ion) contained in the solution with a fluorine ion meter (Orion 1115000 4-Star: manufactured by Thermo Fisher Scientific Co., Ltd.). , The retained fluoride ion concentration (ppm) was obtained.
The fluoride ion retention rate was calculated by the following formula.
Fluoride ion retention rate (%) =
{(Standing Fluoride Ion Concentration (ppm)) / (Fluoride Ion Concentration in Formulation (ppm) / 40)} x 100
From the fluoride ion retention rate, the fluoride ion retention was evaluated according to the following evaluation criteria.
Evaluation Criteria ◎: Fluoride ion retention rate is 50% or more 〇: Fluoride ion retention rate is 30% or more and less than 50% Δ: Fluoride ion retention rate is 20% or more and less than 30% ×: Fluoride ion retention rate is less than 20%
(2)フッ素(フッ素イオン)放出性の評価方法
(1)で△以上の評価の組成(実施例1〜13、比較例2)に対して、ムチンから唾液へのフッ素イオンの放出量(放出率)及び徐放性について評価を行った。
10mL遠心チューブにムチン(Sigma−Aldrich社製)を0.2g添加し、更に歯磨剤組成物(精製水による40倍希釈液)を5mL加え、3分間作用させた。その後、3,000rpmで10分間遠心分離し、上清を除去した。
得られたムチンに、人工唾液(CaCl2=1.5mmol/L、KH2PO4=5.0mmol/L、酢酸=100mmol/L、NaCl=100mmol/L、残部=水;pH=7.0)を5mL加えて1分間撹拌し、3分間、60分間又は180分間静置し、ムチンに吸着・滞留したフッ素イオンを溶出させた後、各々3,000rpmで10分間遠心分離して上清を回収し、溶液に含まれるフッ素イオン濃度をフッ素イオンメーター(Orion 1115000 4−Star:サーモフィッシャーサイエンティフィック(株)製)で測定し、各々の放出フッ素イオン濃度を得た。
放出フッ素イオン濃度から、フッ素イオン放出率を以下の式により算出した。
フッ素イオン放出率(%)=
{(放出フッ素イオン濃度(ppm))/(滞留フッ素イオン濃度(ppm))}×
100
算出したフッ素イオン放出率から、フッ素放出性(放出量)について評価した。
実施例1〜13、比較例2の組成物の3分間静置後のフッ素イオン放出率はいずれも20%未満、60分間静置後のフッ素イオン放出率はいずれも20〜60%の範囲であり、即時放出せず徐放性があることを確認した。
180分間静置後のフッ素イオン放出率から、下記の評価基準でフッ素放出性を評価した。〇又は◎のものが、ムチンに吸着・滞留したフッ素イオンが唾液によって徐々に放出され、フッ素放出性が合格であると判断した。
評価基準
◎:180分間静置後のフッ素イオン放出率が70%以上
〇:180分間静置後のフッ素イオン放出率が50%以上70%未満
△:180分間静置後のフッ素イオン放出率が20%以上50%未満
×:180分間静置後のフッ素イオン放出率が20%未満
(2) Evaluation Method of Fluoride (Fluoride Ion) Release Amount (Release) of Fluoride Ion from Mucin to Saliva with respect to the composition (Examples 1 to 13, Comparative Example 2) evaluated above Δ in (1). Rate) and sustained release were evaluated.
0.2 g of mucin (manufactured by Sigma-Aldrich) was added to a 10 mL centrifuge tube, and 5 mL of a dentifrice composition (40-fold diluted solution with purified water) was further added and allowed to act for 3 minutes. Then, the mixture was centrifuged at 3,000 rpm for 10 minutes to remove the supernatant.
Artificial saliva (CaCl 2 = 1.5 mmol / L, KH 2 PO 4 = 5.0 mmol / L, acetic acid = 100 mmol / L, NaCl = 100 mmol / L, balance = water; pH = 7.0 ) Is added and stirred for 1 minute, allowed to stand for 3 minutes, 60 minutes or 180 minutes to elute the fluoride ions adsorbed and retained in mutin, and then centrifuged at 3,000 rpm for 10 minutes to prepare the supernatant. The fluoride was collected and the concentration of fluoride ions contained in the solution was measured with a fluoride ion meter (Orion 1115000 4-Star: manufactured by Thermo Fisher Scientific Co., Ltd.) to obtain the concentration of each released fluoride ion.
From the released fluoride ion concentration, the fluoride ion release rate was calculated by the following formula.
Fluoride ion release rate (%) =
{(Released fluoride ion concentration (ppm)) / (Standing fluoride ion concentration (ppm))} ×
100
From the calculated fluorine ion release rate, the fluorine release property (release amount) was evaluated.
The fluoride ion release rates of the compositions of Examples 1 to 13 and Comparative Example 2 after standing for 3 minutes were both less than 20%, and the fluoride ion release rates after standing for 60 minutes were all in the range of 20 to 60%. It was confirmed that there was sustained release without immediate release.
From the fluorine ion release rate after standing for 180 minutes, the fluorine release property was evaluated according to the following evaluation criteria. Fluoride ions adsorbed and retained in mucin were gradually released by saliva, and it was judged that the fluorine-releasing property was acceptable.
Evaluation criteria ⊚: Fluoride ion release rate after 180 minutes standing is 70% or more 〇: Fluoride ion release rate after 180 minutes standing is 50% or more and less than 70% Δ: Fluoride ion release rate after 180 minutes standing 20% or more and less than 50% ×: Fluoride ion release rate after standing for 180 minutes is less than 20%
(3)保存安定性の評価方法
(3−1)製剤の液分離安定性(保存後の液分離のなさ)の評価方法
歯磨剤組成物を50gずつチューブ容器(素材:最内層が直鎖状低密度ポリエチレンからなる直径26mmのラミネートチューブ(大日本印刷(株))製)3本に充填し、40℃で1ヶ月間保存した。保存後に各チューブ容器から歯磨剤組成物を紙の上に押し出し、液分離の状態を下記の評点基準で判定した。3本の平均点を求め、下記の評価基準で製剤の液分離安定性を評価した。
評点基準
4点:液分離が全くなかった
3点:口元部に液分離がわずかに認められたが問題ないレベルだった
2点:口元部及び練表面の液分離が認められた
1点:チューブから歯磨を押し出した時、分離液が垂れだす程度に認められた
評価基準
◎:平均点が4.0点
〇:平均点が3.0点以上4.0点未満
△:平均点が2.0点以上3.0点未満
×:平均点が2.0点未満
(3) Evaluation method of storage stability (3-1) Evaluation method of liquid separation stability (no liquid separation after storage) of the preparation 50 g of dentifrice composition in a tube container (material: innermost layer is linear) It was filled in 3 laminated tubes (manufactured by Dainippon Printing Co., Ltd.) having a diameter of 26 mm made of low-density polyethylene and stored at 40 ° C. for 1 month. After storage, the dentifrice composition was extruded onto paper from each tube container, and the state of liquid separation was judged according to the following scoring criteria. The average score of 3 bottles was calculated, and the liquid separation stability of the pharmaceutical product was evaluated according to the following evaluation criteria.
Rating criteria 4 points: No liquid separation at all 3 points: Liquid separation was slightly observed in the mouth but at a level that was not a problem 2 points: Liquid separation was observed in the mouth and kneading surface 1 point: Tube Evaluation criteria recognized to the extent that the separation liquid drips when the toothbrush is extruded from ◎: Average score is 4.0 points 〇: Average score is 3.0 points or more and less than 4.0 points △: Average score is 2. 0 points or more and less than 3.0 points ×: Average score is less than 2.0 points
(3−2)製剤の固化安定性(保存後の固化のなさ)の評価方法
歯磨剤組成物を50gずつチューブ容器(素材:最内層が直鎖状低密度ポリエチレンからなる直径26mmのラミネートチューブ(大日本印刷(株))製)3本に充填し、40℃で1ヶ月間保存した。保存後に各チューブ容器から歯磨剤組成物を押し出し、固化の状態を下記の評点基準で判定した。3本の平均点を求め、下記の評価基準で製剤の固化安定性を評価した。
評点基準
4点:固化が全くなかった
3点:口元部に固化がわずかに認められたが問題ないレベルだった
2点:口元部及び練表面の固化が認められた
1点:チューブから歯磨を押し出せない程度に固化が認められた
評価基準
◎:平均点が4.0点
〇:平均点が3.0点以上4.0点未満
△:平均点が2.0点以上3.0点未満
×:平均点が2.0点未満
(3-2) Evaluation method of solidification stability (non-solidification after storage) of the pharmaceutical product 50 g of dentifrice composition in a tube container (Material: Laminated tube with a diameter of 26 mm made of linear low-density polyethylene in the innermost layer) It was filled in 3 tubes (manufactured by Dai Nippon Printing Co., Ltd.) and stored at 40 ° C. for 1 month. After storage, the dentifrice composition was extruded from each tube container, and the solidified state was judged according to the following scoring criteria. The average score of 3 bottles was calculated, and the solidification stability of the preparation was evaluated according to the following evaluation criteria.
Rating criteria 4 points: No solidification 3 points: Slight solidification was observed in the mouth but at a level that was not a problem 2 points: Solidification of the mouth and kneaded surface was observed 1 point: Toothbrush from the tube Evaluation criteria for solidification to the extent that it cannot be extruded ◎: Average score is 4.0 points 〇: Average score is 3.0 points or more and less than 4.0 points △: Average score is 2.0 points or more and 3.0 points Less than ×: Average score is less than 2.0 points
使用原料の詳細を下記に示す。
(A)ピロリン酸カリウム;太平化学産業(株)製
(A)トリポリリン酸ナトリウム;太平化学産業(株)製
(B)塩化カルシウム;関東化学(株)製
(C)フッ化ナトリウム;ステラケミファ(株)製
(D)ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド;
CELQUAT L−200、アクゾノーベル(株)製、
2%粘度:35〜350mPa・s(BH型ブルックフィールド粘度計、ロー
ターNo.2、20回転、20℃、測定時間1分)、
ポリエチレングリコールを標準物質としたゲルパーミエーションクロマトグラ
フ(GPC)法による重量平均分子量:250,000〜350,000)
Details of the raw materials used are shown below.
(A) Potassium pyrophosphate; Taihei Kagaku Sangyo Co., Ltd. (A) Sodium tripolyphosphate; Taihei Kagaku Sangyo Co., Ltd. (B) Calcium chloride; Kanto Kagaku Co., Ltd. (C) Sodium fluoride; Stella Chemifa ( (D) Hydroxyethyl Cellulose Dimethyldiallyl Ammonium Chloride
CELQUAT L-200, manufactured by AkzoNobel Co., Ltd.,
2% viscosity: 35 to 350 mPa · s (BH type Brookfield viscometer, rotor No. 2, 20 rotations, 20 ° C., measurement time 1 minute),
Weight average molecular weight by gel permeation chromatography (GPC) method using polyethylene glycol as a standard substance: 250,000 to 350,000)
Claims (8)
(B)水溶性カルシウム塩を0.1〜1.5質量%、
(C)フッ化ナトリウム
及び
(D)カチオン化セルロース
を含有することを特徴とする歯磨剤組成物。 (A) 0.1 to 1.5% by mass of one or more selected from tripolyphosphate and pyrophosphate.
(B) 0.1 to 1.5% by mass of water-soluble calcium salt,
A dentifrice composition comprising (C) sodium fluoride and (D) cationized cellulose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019229443A JP7447470B2 (en) | 2019-12-19 | 2019-12-19 | dentifrice composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019229443A JP7447470B2 (en) | 2019-12-19 | 2019-12-19 | dentifrice composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021095380A true JP2021095380A (en) | 2021-06-24 |
JP7447470B2 JP7447470B2 (en) | 2024-03-12 |
Family
ID=76430504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019229443A Active JP7447470B2 (en) | 2019-12-19 | 2019-12-19 | dentifrice composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7447470B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023063180A1 (en) * | 2021-10-12 | 2023-04-20 | ライオン株式会社 | Oral composition |
WO2023120058A1 (en) * | 2021-12-21 | 2023-06-29 | ライオン株式会社 | Oral composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5191339A (en) * | 1974-10-10 | 1976-08-10 | Haenamerushitsuni kobutsuseibuoosaihokyusurutamenososeibutsu | |
JP2006182667A (en) * | 2004-12-27 | 2006-07-13 | Lion Corp | Water-containing oral cavity gel composition |
JP2007161657A (en) * | 2005-12-15 | 2007-06-28 | Lion Corp | Dentifrice composition |
JP2009137863A (en) * | 2007-12-05 | 2009-06-25 | Lion Corp | Oral cavity composition and method for producing oral cavity composition |
JP2013067567A (en) * | 2011-09-21 | 2013-04-18 | Lion Corp | Dentifrice composition |
JP2015117215A (en) * | 2013-12-19 | 2015-06-25 | ライオン株式会社 | Dentifrice composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005052400A1 (en) | 2005-10-31 | 2007-05-03 | Henkel Kgaa | Mouth- and tooth-care product, comprises specific formula incorporating tensides for re-mineralizing of teeth |
JP6471667B2 (en) | 2015-09-28 | 2019-02-20 | ライオン株式会社 | Liquid oral composition |
-
2019
- 2019-12-19 JP JP2019229443A patent/JP7447470B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5191339A (en) * | 1974-10-10 | 1976-08-10 | Haenamerushitsuni kobutsuseibuoosaihokyusurutamenososeibutsu | |
JP2006182667A (en) * | 2004-12-27 | 2006-07-13 | Lion Corp | Water-containing oral cavity gel composition |
JP2007161657A (en) * | 2005-12-15 | 2007-06-28 | Lion Corp | Dentifrice composition |
JP2009137863A (en) * | 2007-12-05 | 2009-06-25 | Lion Corp | Oral cavity composition and method for producing oral cavity composition |
JP2013067567A (en) * | 2011-09-21 | 2013-04-18 | Lion Corp | Dentifrice composition |
JP2015117215A (en) * | 2013-12-19 | 2015-06-25 | ライオン株式会社 | Dentifrice composition |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023063180A1 (en) * | 2021-10-12 | 2023-04-20 | ライオン株式会社 | Oral composition |
WO2023120058A1 (en) * | 2021-12-21 | 2023-06-29 | ライオン株式会社 | Oral composition |
Also Published As
Publication number | Publication date |
---|---|
JP7447470B2 (en) | 2024-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5790455B2 (en) | Dentifrice composition | |
JP5625647B2 (en) | Dentifrice composition | |
JP2016199598A (en) | Compositions for oral cavity | |
JPWO2018194111A1 (en) | Oral biofilm remover and oral composition | |
JP5310556B2 (en) | Oral composition and method for improving astringency of oral composition | |
JP7173043B2 (en) | Oral stain remover, oral stain formation inhibitor, and oral composition | |
JP7447470B2 (en) | dentifrice composition | |
JP5397204B2 (en) | Oral composition | |
JP2011195552A (en) | Composition for oral cavity | |
KR20110107327A (en) | Dentifrice composition | |
JP2015117215A (en) | Dentifrice composition | |
JP2018058795A (en) | Composition for oral cavity and method for suppressing color change of preparation and liquid separation | |
KR102637277B1 (en) | Oral composition | |
JP4656293B2 (en) | Oral composition | |
JP4284522B2 (en) | Toothpaste composition | |
JP3189549B2 (en) | Oral composition | |
JP7255587B2 (en) | Oral composition and α-olefin sulfonate bitterness improver | |
JP7347916B2 (en) | dentifrice composition | |
JP3951085B2 (en) | Dentifrice composition | |
JP5627190B2 (en) | Dentifrice composition | |
JP2002255773A (en) | Composition for oral cavity | |
WO2022264811A1 (en) | Dentifrice composition | |
JP2018203714A (en) | Oral composition | |
JP7371351B2 (en) | Oral composition | |
CN109953897B (en) | Oral composition and method for inhibiting discoloration thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220930 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230823 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230829 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231027 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231102 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240130 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240212 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7447470 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |